# The Use of Aging Biomarkers in Saliva, Based on DNA Methylation Status in Elovl2 to Predict Biological Age

> **NCT03734419** · — · WITHDRAWN · sponsor: **HKGepitherapeutics**

## Conditions studied

- Healthy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03734419
- **Lead sponsor:** HKGepitherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-12-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** IRB approval was not obtained for this study.
- **Last updated:** 2023-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03734419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03734419, "The Use of Aging Biomarkers in Saliva, Based on DNA Methylation Status in Elovl2 to Predict Biological Age". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03734419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*